Neuralink announces its first international trial

Event 8 of 16 in How Neuralink's brain-interface research and trials unfolded

The event

20 Nov 2024

Turning point

Start

Neuralink announces its first international trial

The company said Health Canada had authorised CAN-PRIME and opened recruitment. It described a study of the implant and robot's safety and initial functionality, rather than a commercial treatment launch.

Neuralink Open event

Sources and context

CAN-PRIME study launchCompany statement · Neuralink

Sources for this event

CAN-PRIME study launch Neuralink

Before · 17 Sep 2024
Blindsight receives a development designation, according to NeuralinkAfter · 24 Nov 2024
CONVOY extends research toward an assistive robotic arm

See it in the full timeline (16 events) →